about
Azole cross-resistance in Aspergillus fumigatus.Modification of rapid susceptibility assay for antifungal susceptibility testing of Aspergillus fumigatus.Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards.Extra copies of the Aspergillus fumigatus squalene epoxidase gene confer resistance to terbinafine: genetic approach to studying gene dose-dependent resistance to antifungals in A. fumigatusAntifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003Gene profiling for studying the mechanism of aflatoxin biosynthesis in Aspergillus flavus and A. parasiticus.Antifungal protein PAF severely affects the integrity of the plasma membrane of Aspergillus nidulans and induces an apoptosis-like phenotypeCombined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus.Antifungal susceptibility testing: practical aspects and current challenges.In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results.Ruthmycin, a new tetracyclic polyketide from Streptomyces sp. RM-4-15.Identification of novel genes conferring altered azole susceptibility in Aspergillus fumigatus.Mutations in Aspergillus fumigatus resulting in reduced susceptibility to posaconazole appear to be restricted to a single amino acid in the cytochrome P450 14alpha-demethylase.Has antifungal susceptibility testing come of age?Antifungal activity of redox-active benzaldehydes that target cellular antioxidation.Invasive aspergillosis in patients with hematologic malignancies.Deciphering the mode of action of a mutant Allium sativum Leaf Agglutinin (mASAL), a potent antifungal protein on Rhizoctonia solani.In vitro activities of three licensed antifungal agents against spanish clinical isolates of Aspergillus spp.The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications.Multidrug resistance in fungiSingle-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.Interlaboratory evaluation of hematocytometer method of inoculum preparation for testing antifungal susceptibilities of filamentous fungi.Potent synergistic in vitro interaction between nonantimicrobial membrane-active compounds and itraconazole against clinical isolates of Aspergillus fumigatus resistant to itraconazoleEfflux-mediated antifungal drug resistance.Patterns of susceptibility of Aspergillus isolates recovered from patients enrolled in the Transplant-Associated Infection Surveillance Network.Current relevance of fungal and trypanosomatid glycolipids and sphingolipids: studies defining structures conspicuously absent in mammals.In vitro susceptibility testing in Aspergillus species: an update.Assessment of selection and resistance risk for demethylation inhibitor fungicides in Aspergillus fumigatus in agriculture and medicine: a critical review.Dual transcriptional profiling of a bacterial/fungal confrontation: Collimonas fungivorans versus Aspergillus niger.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolatesUse of turbidimetric growth curves for early determination of antifungal drug resistance of filamentous fungi.Rapid, high-throughput, multiplex, real-time PCR for identification of mutations in the cyp51A gene of Aspergillus fumigatus that confer resistance to itraconazoleCholesterol import by Aspergillus fumigatus and its influence on antifungal potency of sterol biosynthesis inhibitors.Proteomic and transcriptomic analysis of Aspergillus fumigatus on exposure to amphotericin B.In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.Frequency and evolution of Azole resistance in Aspergillus fumigatus associated with treatment failureAmino acid substitution in Trichophyton rubrum squalene epoxidase associated with resistance to terbinafineAzole antifungal resistance in Aspergillus fumigatus: 2008 and 2009.Effect of medium composition on static and cidal activity of amphotericin B, itraconazole, voriconazole, posaconazole and terbinafine against Aspergillus fumigatus: a multicenter study.
P2860
Q28345187-6BA684BE-8615-4862-9216-550438F143DAQ30452373-CF2C2969-7F9E-4366-ADB5-E812B3689D3FQ30453651-4DA641A1-71C5-4EE2-8DFE-81EF2335685DQ30764085-45163651-C113-4A3E-ADF0-4C28DA1E5338Q30981454-A6C9DD07-0A6C-45AD-8BE0-81D5A2E85FAEQ33299858-48BAB349-1979-4DC5-A5A7-9282CB697A32Q33836555-DE0A83CD-E18F-400A-B2DC-6690CF8DD0E0Q33857685-A19D1118-194C-4CBB-B1F1-3D4C64119603Q33975757-E48C000D-2700-4450-AB30-3A384B28A1D5Q34144184-D9F2DD82-0F57-4247-96D6-C35CB9B37EBFQ34392079-A428108C-6C84-453D-AE61-29EC2831CC35Q34452089-63ED3724-A431-49A8-BB0A-6FE4CDD8E9DCQ34823914-B0918E82-3F8A-47A8-AC63-FEFB25D532C4Q34923038-D02DEED1-A5A7-44D6-BF30-A316E588F37BQ35081105-ED30917E-C4F6-4076-B047-97BE29771B2CQ35616161-F98893F3-63FE-4014-93A0-20C06BDCB66AQ35821584-AC2F3EBB-EB08-4E4C-B909-E84958EE17ACQ36047931-AF7692A9-8D28-4259-8652-E51A26359BB9Q36626518-EB7474C2-DC6D-44B0-85A9-F2BCB96F2022Q36943181-BB3EC541-5C5F-4297-9DA5-390BB0C84988Q37036445-75146C1A-17B5-48EA-8258-EA0CC06D6770Q37058525-29C64C83-1287-48D9-AB18-A60E81C2F490Q37119654-360E21D6-1036-4DEB-96E4-E07B4100690BQ37156645-AE192FAE-D4E6-4100-9607-1A9E73749B53Q37374804-BC5A5587-DEF5-41BD-A06E-AA46C37DBF43Q37590188-097F3FDD-3EA1-40EE-A372-6997CE63E3E2Q37742178-E5DB0483-39BC-4EBC-BB0C-B272AACC02EBQ38152396-62B0C1EC-6375-4000-BE5A-5547B3E3E25AQ38256817-8E6BA299-8D89-47C9-8AD2-EC5A973790E3Q38711698-568F764B-EECF-462D-A651-6BFF527DFE36Q39653016-0F536EF2-E878-4E68-9DD7-807EF9F8EE95Q40133093-C130DB7C-FDAA-461A-91DB-59236F855B49Q40771905-21B3D202-0AAB-4C75-A7A7-E46B80F294EFQ41004012-1438BF55-91E5-47B8-9705-7E1DC9FD373DQ41389247-6E295C3D-C8A1-4691-BD73-572EE52484F7Q41511867-9BA06285-F587-4E6B-B6ED-F449C96170C1Q42555868-79D8D1B1-8756-4802-8F8E-1CC063965DC0Q42588002-1EA7BBA0-FE39-48C6-9ACA-5F3913466CEAQ42930104-4C53C266-FDB9-4623-99C0-78626790C982Q44066015-7BD7C7E2-88F3-4815-BEC0-D97CD526A98F
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Antifungal drug resistance in Aspergillus.
@ast
Antifungal drug resistance in Aspergillus.
@en
Antifungal drug resistance in Aspergillus.
@nl
type
label
Antifungal drug resistance in Aspergillus.
@ast
Antifungal drug resistance in Aspergillus.
@en
Antifungal drug resistance in Aspergillus.
@nl
prefLabel
Antifungal drug resistance in Aspergillus.
@ast
Antifungal drug resistance in Aspergillus.
@en
Antifungal drug resistance in Aspergillus.
@nl
P2093
P356
P1433
P1476
Antifungal drug resistance in Aspergillus.
@en
P2093
P304
P356
10.1053/JINF.2000.0747
P577
2000-11-01T00:00:00Z